A nomogram based on circulating CD8+ T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

A nomogram based on circulating CD8+ T cell and platelet-to-lymphocyte ratio to predict overall survival of patients with locally advanced nasopharyngeal carcinoma

Published:2024-08-13 Issue:1 Volume:19 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Yan Chang,Yang Guohai,Zhang Chaojun,Chen KaiHua,Sun Yongchu,Liang Zhongguo,Lai Lin,Li Ling,Qu Song,Zhu Xiao-Dong

Funder

the Key Research and Development Program Project of Guangxi Zhuang Autonomous Region

Natural Science Foundation of Guangxi Zhuang Autonomous Region

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13014-024-02500-y.pdf

Reference43 articles.

1. Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet (London England). 2019;394(10192):64–80.

2. Chang ET, Ye W, Zeng YX, Adami HO. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1035–47.

3. Li WF, Chen NY, Zhang N, et al. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trial. Int J Cancer. 2019;145(1):295–305.

4. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American joint committee on cancer/international union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncology Off J Am Soc Clin Oncol. 2005;23(27):6730–8.

5. Yang J, Liang ZG, Jiang YT, et al. Efficacy and safety of concurrent chemoradiotherapy combined with induction chemotherapy or adjuvant chemotherapy in patients with stage II-IVA nasopharyngeal carcinoma: a propensity score matching analysis and meta-analysis. Front Oncol. 2021;11:778836.